Antibodies in proteomics I: Generating antibodies

Trends in Biotechnology

Volumn 21, Issue 6, 2003, Pages 275-281

  Bradbury, Andrew ^a   Velappan, Nileena ^a   Verzillo, Vittorio ^b   Ovecka, Milan ^a   Chasteen, Leslie ^a   Sblattero, Daniele ^c   Marzari, Roberto ^c   Lou, Jianlong ^b   Siegel, Robert ^d   Pavlik, Peter ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TRIESTE   (Italy)

^d PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GENES; IMMUNIZATION; PROTEINS;

PROTEOMICS;

ANTIBODIES;

ANTIBODY; LIGAND; MONOCLONAL ANTIBODY;

ANTIBODY; BIOTECHNOLOGY; GENOME;

DISPLAY SYSTEM; DNA MICROARRAY; GENE EXPRESSION; GENE SEQUENCE; GENETIC SELECTION; GENOME; IMMUNIZATION; LIGAND BINDING; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEOMICS; REPRODUCIBILITY; REVIEW; YEAST;

EID: 12444317574     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-7799(03)00112-4     Document Type: Review

References (91)

1. Venter J.C., et al. The sequence of the human genome. Science. 291:2001;1304-1351.
2. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
3. Goffeau A., et al. Life with 6000 genes. Science. 274:1996;546-567.
4. Ross-Macdonald P., et al. Large-scale analysis of the yeast genome by transposon tagging and gene disruption. Nature. 402:1999;413-418.
5. Zhu H., et al. Global analysis of protein activities using proteome chips. Science. 293:2001;2101-2105.
6. Kumar A., et al. Subcellular localization of the yeast proteome. Genes Dev. 16:2002;707-719.
7. Tong A.H., et al. A combined experimental and computational strategy to define protein interaction networks for peptide recognition modules. Science. 295:2002;321-324.
8. Uetz P., et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature. 403:2000;623-627.
9. Schwikowski B., et al. A network of protein-protein interactions in yeast. Nat. Biotechnol. 18:2000;1257-1261.
10. Ho Y., et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature. 415:2002;180-183.
11. Gavin A.C., et al. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature. 415:2002;141-147.
12. Anderer F.A., Schlumberger H.D. Cross-reactions of antisera against the terminal amino acid and dipeptide of tobacco mosaic virus. Biochim. Biophys. Acta. 115:1966;222-224.
13. Tang D.-C., et al. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
14. Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 256:1975;495-497.
15. Cwirla S.E., et al. Peptides on phage: a vast library of peptides for identifying ligands. Proc. Natl. Acad. Sci. U. S. A. 87:1990;6378-6382.
16. Scott J.K., Smith G.P. Searching for peptide ligands with an epitope library. Science. 249:1990;386-390.
17. Kay B.K., et al. An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets. Gene. 128:1993;59-65.
18. McCafferty J., et al. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 348:1990;552-554.
19. Huie M.A., et al. Antibodies to human fetal erythroid cells from a nonimmune phage antibody library. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2682-2687.
20. Vaughan T.J., et al. Human antibodies with sub-nanomolar affinities isolated from a large non-immunised phage display library. Nat. Biotechnol. 14:1996;309-314.
21. Sblattero D., Bradbury A. Exploiting recombination in single bacteria to make large phage antibody libraries. Nat. Biotechnol. 18:2000;75-80.
22. de Haard H.J., et al. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J. Biol. Chem. 274:1999;18218-18230.
23. Sheets M.D., et al. Efficient construction of a large nonimmune phage antibody library; the production of panels of high affinity human single-chain antibodies to protein antigens. Proc. Natl. Acad. Sci. U. S. A. 95:1998;6157-6162.
24. Knappik A., et al. Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J. Mol. Biol. 296:2000;57-86.
25. Lowman H.B., Wells J.A. Affinity maturation of human growth hormone by monovalent phage display. J. Mol. Biol. 234:1993;564-578.
26. Lowman H.B. Bacteriophage display and discovery of peptide leads for drug development. Annu. Rev. Biophys. Biomol. Struct. 26:1997;401-424.
27. Hoogenboom H.R., et al. Antibody phage display technology and its applications. Immunotechnology. 4:1998;1-20.
28. Bradbury A., Cattaneo A. The use of phage display in neurobiology. Trends Neurosci. 18:1995;243-249.
29. Francisco J.A., et al. Transport and anchoring of β-lactamase to the external surfaceof Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 89:1992;2713-2717.
30. Boder E.T., Wittrup K.D. Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15:1997;553-557.
31. Hanes J., Plückthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc. Natl. Acad. Sci. U. S. A. 94:1997;4937-4942.
32. Roberts R.W., Szostak J.W. RNA-peptide fusions for the in vitro selection of peptides and proteins. Proc. Natl. Acad. Sci. U. S. A. 94:1997;12297-12302.
33. Fields S., Song O. A novel genetic system to detect protein-protein interactions. Nature. 340:1989;245-246.
34. Pelletier J.N., et al. An in vivo library-versus-library selection of optimized protein-protein interactions. Nat. Biotechnol. 17:1999;683-690.
35. Visintin M., et al. Selection of antibodies for intracellular function using a two-hybrid in vivo system. Proc. Natl. Acad. Sci. U. S. A. 96:1999;11723-11728.
36. Auf-der-Maur A., et al. Antigen-independent selection of stable intracellular single-chain antibodies. FEBS Lett. 508:2001;407-412.
37. Mossner E., et al. Fast selection of antibodies without antigen purification: adaptation of the protein fragment complementation assay to select antigen-antibody pairs. J. Mol. Biol. 308:2001;115-122.
38. Skerra A. Engineered protein scaffolds for molecular recognition. J. Mol. Recognit. 13:2000;167-187.
39. Hawkins R.E., et al. Selection of phage antibodies by binding affinity: mimicking affinity maturation. J. Mol. Biol. 226:1992;889-896.
40. Francisco J.A., et al. Production and fluorescence-activated cell sorting of Escherichia coli expressing a functional antibody fragment on the external surface. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10444-10448.
41. de Wildt R.M., et al. Antibody arrays for high-throughput screening of antibody-antigen interactions. Nat. Biotechnol. 18:2000;989-994.
42. Daugherty P.S., et al. Antibody affinity maturation using bacterial surface display. Protein Eng. 11:1998;825-832.
43. Boder E.T., et al. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10701-10705.
44. Shusta E.V., et al. Yeast polypeptide fusion surface display levels predict thermal stability and soluble secretion efficiency. J. Mol. Biol. 292:1999;949-956.
45. Feldhaus M.J., et al. Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat. Biotechnol. 21:2003;163-170.
46. Persic L., et al. Single-chain variable fragments selected on the 57-76 p21Ras neutralising epitope from phage antibody libraries recognise the native protein. FEBS Lett. 443:1999;112-116.
47. Van Beijnum J.R., et al. Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. Int. J. Cancer. 101:2002;118-127.
48. Liu B., et al. Towards proteome-wide production of monoclonal antibody by phage display. J. Mol. Biol. 315:2002;1063-1073.
49. Sblattero D., et al. In vivo recombination as a tool to generate molecular diversity in phage antibody libraries. J. Biotechnol. 74:2001;303-315.
50. Griffiths A.D., et al. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13:1994;3245-3260.
51. Yang W.P., et al. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range. J. Mol. Biol. 254:1995;392-403.
52. Schier R., et al. Isolation of picomolar affinity anti-c-erB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. J. Mol. Biol. 263:1996;551-567.
53. Thompson J., et al. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity. J. Mol. Biol. 256:1996;77-88.
54. Pack P., Pluckthun A. Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli. Biochemistry. 31:1992;1579-1584.
55. Lou J., et al. Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries. J. Immunol. Methods. 253:2001;233-242.
56. Kipriyanov S.M., et al. Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity. Protein Eng. 10:1997;445-453.
57. Duenas M., et al. A point mutation in a murine immunoglobulin V-region strongly influences the antibody yield in Escherichia coli. Gene. 158:1995;61-66.
58. Coia G., et al. Use of mutator cells as a means for increasing production levels of a recombinant antibody directed against hepatitis B. Gene. 201:1997;203-209.
59. Krebs B., et al. High-throughput generation and engineering of recombinant human antibodies. J. Immunol. Methods. 254:2001;67-84.
60. Desiderio A., et al. A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold. J. Mol. Biol. 310:2001;603-615.
61. Holt L.J., et al. By-passing selection: direct screening for antibody-antigen interactions using protein arrays. Nucleic Acids Res. 28:2000;E72.
62. Boder E.T., Wittrup K.D. Yeast surface display for directed evolution of protein expression, affinity, and stability. Methods Enzymol. 328:2000;430-444.
63. Nemoto N., et al. In vitro virus: bonding of mRNA bearing puromycin at the 3′-terminal end to the C-terminal end of its encoded protein on the ribosome in vitro. FEBS Lett. 414:1997;405-408.
64. He M., Taussig M.J. Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res. 25:1997;5132-5134.
65. Hanes J., et al. Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display. Nat. Biotechnol. 18:2000;1287-1292.
66. Hanes J., et al. Selecting and evolving functional proteins in vitro by ribosome display. Methods Enzymol. 328:2000;404-430.
67. Stemmer W.P. DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. Proc. Natl. Acad. Sci. U. S. A. 91:1994;10747-10751.
68. Sawasaki T., et al. A bilayer cell-free protein synthesis system for high-throughput screening of gene products. FEBS Lett. 514:2002;102-105.
69. Xu L., et al. Directed evolution of high-affinity antibody mimics using mRNA display. Chem. Biol. 9:2002;933-942.
70. Lesley S.A. High-throughput proteomics: protein expression and purification in the postgenomic world. Protein Expr. Purif. 22:2001;159-164.
71. Lesley S.A., et al. Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11664-11669.
72. Visintin M., et al. The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies. J. Mol. Biol. 317:2002;73-83.
73. Tse E., et al. Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein. J. Mol. Biol. 317:2002;85-94.
74. Joung J.K., et al. A bacterial two-hybrid selection system for studying protein-DNA and protein-protein interactions. Proc. Natl. Acad. Sci. U. S. A. 97:2000;7382-7387.
75. Karimova G., et al. A bacterial two-hybrid system based on a reconstituted signal transduction pathway. Proc. Natl. Acad. Sci. U. S. A. 95:1998;5752-5756.
76. Dove S.L., Hochschild A. Conversion of the omega subunit of Escherichia coli RNA polymerase into a transcriptional activator or an activation target. Genes Dev. 12:1998;745-754.
77. Dove S.L., et al. Activation of prokaryotic transcription through arbitrary protein-protein contacts. Nature. 386:1997;627-630.
78. Michnick S.W. Exploring protein interactions by interaction-induced folding of proteins from complementary peptide fragments. Curr. Opin. Struct. Biol. 11:2001;472-477.
79. Galarneau A., et al. Beta-lactamase protein fragment complementation assays as in vivo and in vitro sensors of protein-protein interactions. Nat. Biotechnol. 20:2002;619-622.
80. Worn A., Pluckthun A. Stability engineering of antibody single-chain Fv fragments. J. Mol. Biol. 305:2001;989-1010.
81. Proba K., et al. Antibody scFv fragments without disulfide bonds made by molecular evolution. J. Mol. Biol. 275:1998;245-253.
82. Jung S., et al. Selection for improved protein stability by phage display. J. Mol. Biol. 294:1999;163-180.
83. Martineau P., et al. Expression of an antibody fragment at high levels in the bacterial cytoplasm. J. Mol. Biol. 280:1998;117-127.
84. Kabat E.A., et al. U.S. Department of Health and Human Services. U.S. Department of Health and Human Services. 1991;U.S. Government Printing Office.
85. Ohage E.C., et al. Intrabody construction and expression. II. A synthetic catalytic Fv fragment. J. Mol. Biol. 291:1999;1129-1134.
86. Steipe B., et al. Sequence statistics reliably predict stabilizing mutations in a protein domain. J. Mol. Biol. 240:1994;188-192.
87. Ohage E., Steipe B. Intrabody construction and expression. I. The critical role of VL domain stability. J. Mol. Biol. 291:1999;1119-1128.
88. Wirtz P., Steipe B. Intrabody construction and expression III: engineering hyperstable V(H) domains. Protein Sci. 8:1999;2245-2250.
89. Cattaneo A., Biocca S. Intracellular antibodies: developments and applications. 1997;Landes Bioscience, Academic Press.
90. Bach H., et al. Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies. J. Mol. Biol. 312:2001;79-93.
91. de Wildt R.M., et al. Isolation of receptor-ligand pairs by capture of long-lived multivalent interaction complexes. Proc. Natl. Acad. Sci. U. S. A. 99:2002;8530-8535.